Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | TAR | Tiphaine Christiane Martin | |||||||
GSM5646656 |
GEX_Multiplexed_sample1 (IgGControl and anti-CD47) 3 reps
|
SRA | 1 |
|
Tiphaine Christiane Martin | Oct 30, 2023 | |||
GSM5646657 |
HTO_Multiplexed_sample1 (IgG_Control and anti-CD47) 3 reps
|
SRA | 1 |
|
Tiphaine Christiane Martin | Oct 30, 2023 | |||
GSM5646658 |
GEX_Multiplexed_sample2 (anti-B7-H3 and anti-B7-H3 + anti-CD47) 3 reps
|
SRA | 1 |
|
Tiphaine Christiane Martin | Oct 30, 2023 | |||
GSM5646659 |
HTO_Multiplexed_sample2 (anti-B7-H3 and anti-B7-H3 + anti-CD47) 3 reps
|
SRA | 1 |
|
Tiphaine Christiane Martin | Oct 30, 2023 | |||
GSM6742894 |
CD34+ HSPCs, day 0, mRNA-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM6742895 |
CD34+ HSPCs, day 0, ADT-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM6742896 |
CD34+ HSPCs, day 1 under VPA treatment, mRNA-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM6742897 |
CD34+ HSPCs, day 1 under VPA treatment, ADT-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM6742898 |
CD34+ HSPCs, day 4 under VPA treatment, mRNA-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM6742899 |
CD34+ HSPCs, day 4 under VPA treatment, ADT-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM7051765 |
CD34+ HSPCs, day 1 under cytokine treatment, mRNA-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM7051766 |
CD34+ HSPCs, day 1 under cytokine treatment, ADT-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM7051767 |
CD34+ HSPCs, day 4 under cytokine treatment, mRNA-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 | |||
GSM7051768 |
CD34+ HSPCs, day 4 under cytokine treatment, ADT-derived cDNA
|
SRA | 1 |
|
Tiphaine Christiane Martin | Apr 11, 2023 |